COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02876003
Recruitment Status : Withdrawn (This study has been withdrawn prior to enrollment.)
First Posted : August 23, 2016
Last Update Posted : February 24, 2017
John Wayne Cancer Institute
Information provided by (Responsible Party):
GenSpera, Inc.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : October 2019
Estimated Study Completion Date : October 2020